行情

TRIB

TRIB

Trinity Biotech
NASDAQ

实时行情|Nasdaq Last Sale

1.000
+0.040
+4.17%
休市 16:00 02/21 EST
开盘
1.000
昨收
0.9600
最高
1.020
最低
0.9901
成交量
4.25万
成交额
--
52周最高
3.360
52周最低
0.6300
市值
2,404.05万
市盈率(TTM)
-0.6941
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测TRIB价格均价为6.00,最高价位6.00,最低价为6.00。

EPS

TRIB 新闻

更多
  • 巴菲特:若利率保持低位 股票收益肯定会胜过债券
  • 新浪美股 · 1小时前
  • 巴菲特:对公司乐观的五个因素
  • 新浪财经 · 1小时前
  • 你想知道的巴菲特全说了!低利率有利股市、收购符合标准的企业…
  • 新浪财经综合 · 1小时前
  • 巴菲特:伯克希尔是保险业的“堡垒”
  • 新浪财经 · 1小时前

所属板块

医疗设备、用品及经销
-0.81%
医疗设备和用品
-0.65%

热门股票

代码
价格
涨跌幅
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

TRIB 简况

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.
展开

微牛提供Trinity Biotech plc (ADR)(NASDAQ-TRIB)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的TRIB股票新闻,以帮助您做出投资决策。